OncoQuest Inc. announced the appointment of Hany Awadalla, as its Senior Vice President and Chief Financial Officer. Mr. Awadalla has spent almost 30 years in healthcare investment banking at Merrill Lynch, UBS, and serving as Head of Healthcare M&A at Robertson Stephens and Wells Fargo and Head of Healthcare Investment Banking at Unterberg Towbin. Most recently and for the past 6 years, he served as Managing Director at National Securities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | +25.00% | +25.00% | -54.55% |
05-30 | Quest Pharmatech Inc. Announces the Appointment of Bradley J. Glass to the Board of Directors | CI |
05-29 | Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-54.55% | 3.07M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- QPT Stock
- News Quest PharmaTech Inc.
- OncoQuest Inc. Appoints Hany Awadalla, as Senior Vice President and Chief Financial Officer